Co-Diagnostics (CODX) Stock Forecast & Price Target

CODX Forecast - Frequently Asked Questions

What is Co-Diagnostics' forecast for 2025?

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Co-Diagnostics is $1.50, with a high forecast of $1.50 and a low forecast of $1.50.

Should I buy or sell Co-Diagnostics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Co-Diagnostics in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CODX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CODX, but not buy additional shares or sell existing shares.

Does Co-Diagnostics's stock price have much upside?

According to analysts, Co-Diagnostics's stock has a predicted upside of 105.48% based on their 12-month stock forecasts.

What analysts cover Co-Diagnostics?

Co-Diagnostics has been rated by research analysts at HC Wainwright in the past 90 days.

Do Wall Street analysts like Co-Diagnostics more than its competitors?

Analysts like Co-Diagnostics less than other "medical" companies. The consensus rating for Co-Diagnostics is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CODX compares to other companies.